Reference
Nakamura K, et al. Axitinib-induced reversible posterior leukoencephalopathy syndrome in a patient with metastatic renal cell carcinoma. International Cancer Conference Journal 6: 197-199, No. 4, Oct 2017. Available from: URL: http://doi.org/10.1007/s13691-017-0306-x - Japan
Rights and permissions
About this article
Cite this article
Axitinib/sunitinib. Reactions Weekly 1679, 33 (2017). https://doi.org/10.1007/s40278-017-38758-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-38758-8